VELIN-PHARMA A/S: Financial statements 2017
CVR: 33026013
Source: annual report 2017, Danish Business Authority
01/06/2016 – 31/05/2017
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 163,832 and a net result of DKK -147,228 compared with DKK 1,107,624 the year before. That is a decrease of 62.7% compared with the year before. Equity in the 2017 report amounted to DKK 20,491,631. The solvency ratio was 97.9%.
- Gross Profit
- DKK 163,832
- Profit/Loss
- DKK -147,228
- Equity
- DKK 20,491,631
- Total Assets
- DKK 20,928,499
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 164 t. | -147 t. | 20.5 mio. | - |
| 2016 | - | 439 t. | 1.1 mio. | 20.6 mio. | - |
| 2015 | - | 518 t. | 1.7 mio. | 19.5 mio. | - |
| 2014 | - | 299 t. | 2 mio. | 17.8 mio. | - |
| 2013 | - | 72 t. | 1.1 mio. | 15.9 mio. | - |
Official annual report
Keep an eye on VELIN-PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.